Integra Lifesciences Holdings Corp (IART)
28.84
+0.11
(+0.38%)
USD |
NASDAQ |
Jul 05, 16:00
28.84
0.00 (0.00%)
After-Hours: 16:23
Integra Lifesciences Holdings SG&A Expense (TTM): 655.78M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 655.78M |
December 31, 2023 | 656.64M |
September 30, 2023 | 645.43M |
June 30, 2023 | 627.30M |
March 31, 2023 | 623.05M |
December 31, 2022 | 616.32M |
September 30, 2022 | 626.65M |
June 30, 2022 | 638.84M |
March 31, 2022 | 640.74M |
December 31, 2021 | 637.44M |
September 30, 2021 | 637.58M |
June 30, 2021 | 631.65M |
March 31, 2021 | 585.21M |
December 31, 2020 | 594.53M |
September 30, 2020 | 606.39M |
June 30, 2020 | 629.41M |
March 31, 2020 | 678.68M |
December 31, 2019 | 687.60M |
September 30, 2019 | 690.57M |
June 30, 2019 | 690.83M |
March 31, 2019 | 702.05M |
December 31, 2018 | 690.75M |
September 30, 2018 | 704.16M |
June 30, 2018 | 676.75M |
March 31, 2018 | 645.16M |
Date | Value |
---|---|
December 31, 2017 | 624.10M |
September 30, 2017 | 545.58M |
June 30, 2017 | 511.95M |
March 31, 2017 | 486.15M |
December 31, 2016 | 455.63M |
September 30, 2016 | 453.26M |
June 30, 2016 | 454.37M |
March 31, 2016 | 434.47M |
December 31, 2015 | 415.76M |
September 30, 2015 | 398.50M |
June 30, 2015 | 378.86M |
March 31, 2015 | 394.79M |
December 31, 2014 | 409.87M |
September 30, 2014 | 343.53M |
June 30, 2014 | 349.54M |
March 31, 2014 | 337.56M |
December 31, 2013 | 332.19M |
September 30, 2013 | 402.57M |
June 30, 2013 | 395.85M |
March 31, 2013 | 388.67M |
December 31, 2012 | 373.11M |
September 30, 2012 | 371.39M |
June 30, 2012 | 365.82M |
March 31, 2012 | 365.46M |
December 31, 2011 | 358.13M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
585.21M
Minimum
Mar 2021
690.57M
Maximum
Sep 2019
637.36M
Average
637.44M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
OraSure Technologies Inc | 84.74M |
Boston Scientific Corp | 5.339B |
Insulet Corp | 771.90M |
ResMed Inc | 915.63M |
Stryker Corp | 7.188B |